PureTech Health (PRTC) Cash & Current Investments (2019 - 2025)

PureTech Health (PRTC) has 6 years of Cash & Current Investments data on file, last reported at $277.3 million in Q4 2025.

• Quarterly Cash & Current Investments fell 38.92% year-over-year to $277.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $277.3 million (down 38.92% YoY) and the FY2025 annual result came in at $277.3 million, down 38.92% from the prior year.
• Cash & Current Investments eased to $277.3 million in Q4 2025 per PRTC's latest filing, from $319.9 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $465.7 million in Q4 2021 and bottomed at $277.3 million in Q4 2025.
• The 4-year median for Cash & Current Investments is $350.1 million (2022), against an average of $373.4 million.
• The widest annual swing landed in 2021, when Cash & Current Investments climbed 15.31%; it then sank 38.92% in 2025.
• Tracing PRTC's Cash & Current Investments over 4 years: stood at $465.7 million in 2021, then dropped by 24.83% to $350.1 million in 2022, then rose by 29.68% to $454.0 million in 2024, then slumped by 38.92% to $277.3 million in 2025.
• Per Business Quant, the three latest PRTC Cash & Current Investments figures stand at $277.3 million (Q4 2025), $319.9 million (Q2 2025), and $454.0 million (Q4 2024).

Peer Comparison